title: The PAR1 antagonist, SCH79797, alters platelet morphology and function independently of PARs.
authors.forename: Hannah
authors.initials: H
authors.lastname: Lee
authors.forename: Justin R
authors.initials: JR
authors.lastname: Hamilton
mesh_terms: D000818:Animals; D001792:Blood Platelets / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology; D048430:Cell Shape / Q000187:drug effects*; D004305:Dose-Response Relationship, Drug; D006801:Humans; D051379:Mice; D018345:Mice, Knockout; D010718:Phosphatidylserines / Q000097:blood*; D010974:Platelet Aggregation / Q000187:drug effects; D010975:Platelet Aggregation Inhibitors / Q000494:pharmacology*; D011758:Pyrroles / Q000494:pharmacology*; D011799:Quinazolines / Q000494:pharmacology*; D044463:Receptor, PAR-1 / Q000097:blood / Q000172:deficiency / Q000235:genetics; D013997:Time Factors
chemical_list: C415424:N3-cyclopropyl-7-((4-(1-methylethyl)phenyl)methyl)-7H-pyrrolo(3, 2-f)quinazoline-1,3-diamine; D010718:Phosphatidylserines; D010975:Platelet Aggregation Inhibitors; D011758:Pyrroles; D011799:Quinazolines; D044463:Receptor, PAR-1